Andre Mauricio de Souza Fernandes

  • Citations Per Year
Learn More
OBJECTIVES Dabigatran is a direct thrombin inhibitor shown to be an effective alternative to warfarin in patients with non-valvular atrial fibrillation (AF). We evaluated the use of dabigatran in patients with bioprosthetic mitral and/or aortic valve replacement and AF. METHODS We selected 34 and randomized 27 patients in a 1:1 ratio to receive dabigatran(More)
  • 1